Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn if drugs as cyclophosphamide (C) and etoposide (E) work to treat advanced head and neck cancer in adults. It will also learn about the safety of both drugs....
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Cancer Institute, Egypt
NCT07463573 · Esophageal Squamous Cell Carcinoma (ESCC)
NCT05268614 · Oropharyngeal Squamous Cell Carcinoma
NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more
NCT06563479 · HPV-Related Squamous Cell Carcinoma
NCT06532279 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, and more
National Cancer Institute
Cairo, Cairo Governorate
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions